MFDS — authorised 30 January 2004
- Marketing authorisation holder: BOEHRINGER INGELHEIM
- Status: likely_approved
🇰🇷 Spiriva in South Korea
MFDS authorised Spiriva on 30 January 2004
Marketing authorisation
Spiriva in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Respiratory approved in South Korea
Frequently asked questions
Is Spiriva approved in South Korea?
Yes. MFDS authorised it on 30 January 2004.
Who is the marketing authorisation holder for Spiriva in South Korea?
BOEHRINGER INGELHEIM holds the South Korean marketing authorisation.